-->

Tag: non‑muscle‑invasive bladder cancer

Home / non‑muscle‑invasive bladder cancer

Categories

Mitomycin intravesical solution is approved by the USFDA for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer

On June 12, 2025, the Food and Drug Administration approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for adults with recurring low-grade intermediate-risk non-muscle invasive bladder c...
non%e2%80%91muscle%e2%80%91invasive-bladder-cancer

Scan the code